KR20220085088A - Food additives to improve immune diseases using herbal medicines from Kamigongjindan - Google Patents
Food additives to improve immune diseases using herbal medicines from Kamigongjindan Download PDFInfo
- Publication number
- KR20220085088A KR20220085088A KR1020200174448A KR20200174448A KR20220085088A KR 20220085088 A KR20220085088 A KR 20220085088A KR 1020200174448 A KR1020200174448 A KR 1020200174448A KR 20200174448 A KR20200174448 A KR 20200174448A KR 20220085088 A KR20220085088 A KR 20220085088A
- Authority
- KR
- South Korea
- Prior art keywords
- mass ratio
- composition
- ginseng
- enhancing immunity
- turmeric
- Prior art date
Links
- 208000026278 immune system disease Diseases 0.000 title claims description 13
- 241000411851 herbal medicine Species 0.000 title description 4
- 235000013373 food additive Nutrition 0.000 title description 2
- 239000002778 food additive Substances 0.000 title description 2
- 239000000203 mixture Substances 0.000 claims abstract description 57
- 230000036039 immunity Effects 0.000 claims abstract description 29
- 230000002708 enhancing effect Effects 0.000 claims abstract description 23
- 239000000284 extract Substances 0.000 claims abstract description 22
- 210000003056 antler Anatomy 0.000 claims abstract description 21
- 235000008434 ginseng Nutrition 0.000 claims abstract description 19
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 18
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 18
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 18
- 239000000843 powder Substances 0.000 claims abstract description 18
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims abstract description 17
- 235000003392 Curcuma domestica Nutrition 0.000 claims abstract description 17
- 235000002789 Panax ginseng Nutrition 0.000 claims abstract description 17
- 235000017803 cinnamon Nutrition 0.000 claims abstract description 17
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 17
- 235000013976 turmeric Nutrition 0.000 claims abstract description 17
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 15
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 15
- 239000006187 pill Substances 0.000 claims abstract description 15
- YEFOAORQXAOVJQ-RZFZLAGVSA-N schisandrol a Chemical compound C1[C@H](C)[C@@](C)(O)CC2=CC(OC)=C(OC)C(OC)=C2C2=C1C=C(OC)C(OC)=C2OC YEFOAORQXAOVJQ-RZFZLAGVSA-N 0.000 claims abstract description 15
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 13
- 240000004385 Centaurea cyanus Species 0.000 claims abstract description 13
- 235000005940 Centaurea cyanus Nutrition 0.000 claims abstract description 13
- 241000207199 Citrus Species 0.000 claims abstract description 13
- 235000020971 citrus fruits Nutrition 0.000 claims abstract description 13
- 230000036541 health Effects 0.000 claims abstract description 13
- 235000013376 functional food Nutrition 0.000 claims abstract description 12
- 238000011084 recovery Methods 0.000 claims abstract description 11
- 241000402754 Erythranthe moschata Species 0.000 claims abstract description 9
- 210000004207 dermis Anatomy 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 6
- 241000208340 Araliaceae Species 0.000 claims abstract description 4
- 244000241838 Lycium barbarum Species 0.000 claims abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 241000282994 Cervidae Species 0.000 claims description 9
- 208000026935 allergic disease Diseases 0.000 claims description 7
- 239000004480 active ingredient Substances 0.000 claims description 4
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 206010020751 Hypersensitivity Diseases 0.000 claims description 3
- 206010039085 Rhinitis allergic Diseases 0.000 claims description 3
- 201000010105 allergic rhinitis Diseases 0.000 claims description 3
- 201000008937 atopic dermatitis Diseases 0.000 claims description 3
- 208000024827 Alzheimer disease Diseases 0.000 claims description 2
- 208000032467 Aplastic anaemia Diseases 0.000 claims description 2
- 206010010744 Conjunctivitis allergic Diseases 0.000 claims description 2
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 2
- 206010035664 Pneumonia Diseases 0.000 claims description 2
- 201000004681 Psoriasis Diseases 0.000 claims description 2
- 208000002205 allergic conjunctivitis Diseases 0.000 claims description 2
- 230000007815 allergy Effects 0.000 claims description 2
- 208000006673 asthma Diseases 0.000 claims description 2
- 208000024998 atopic conjunctivitis Diseases 0.000 claims description 2
- 208000010928 autoimmune thyroid disease Diseases 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 206010025135 lupus erythematosus Diseases 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- 230000001737 promoting effect Effects 0.000 claims description 2
- 206010039073 rheumatoid arthritis Diseases 0.000 claims description 2
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 abstract description 12
- 238000002360 preparation method Methods 0.000 abstract description 8
- 239000000825 pharmaceutical preparation Substances 0.000 abstract description 6
- 239000004615 ingredient Substances 0.000 abstract description 5
- 230000006872 improvement Effects 0.000 abstract description 4
- 230000001965 increasing effect Effects 0.000 abstract description 4
- 235000009508 confectionery Nutrition 0.000 abstract description 3
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 240000004371 Panax ginseng Species 0.000 description 17
- 244000241872 Lycium chinense Species 0.000 description 13
- 239000002253 acid Substances 0.000 description 12
- 239000003921 oil Substances 0.000 description 11
- 239000003814 drug Substances 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- -1 that is Chemical compound 0.000 description 9
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 206010016256 fatigue Diseases 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 6
- 229930006000 Sucrose Natural products 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000005720 sucrose Substances 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- 229930182490 saponin Natural products 0.000 description 5
- 150000007949 saponins Chemical class 0.000 description 5
- 235000017709 saponins Nutrition 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 241001672694 Citrus reticulata Species 0.000 description 4
- 229930091371 Fructose Natural products 0.000 description 4
- 239000005715 Fructose Substances 0.000 description 4
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 4
- 108010010803 Gelatin Proteins 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000009691 Gongjin-dan Substances 0.000 description 4
- 241000282414 Homo sapiens Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- HLXRWTJXGMHOFN-XJSNKYLASA-N Verbenalin Chemical compound O([C@@H]1OC=C([C@H]2C(=O)C[C@H](C)[C@H]21)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HLXRWTJXGMHOFN-XJSNKYLASA-N 0.000 description 4
- 229940076810 beta sitosterol Drugs 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 4
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 235000003599 food sweetener Nutrition 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 229920000159 gelatin Polymers 0.000 description 4
- 239000008273 gelatin Substances 0.000 description 4
- 235000019322 gelatine Nutrition 0.000 description 4
- 235000011852 gelatine desserts Nutrition 0.000 description 4
- 210000000987 immune system Anatomy 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 229950005143 sitosterol Drugs 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- ATHGHQPFGPMSJY-UHFFFAOYSA-N spermidine Chemical compound NCCCCNCCCN ATHGHQPFGPMSJY-UHFFFAOYSA-N 0.000 description 4
- 239000003765 sweetening agent Substances 0.000 description 4
- 238000003809 water extraction Methods 0.000 description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- 206010018910 Haemolysis Diseases 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 240000006079 Schisandra chinensis Species 0.000 description 3
- 235000008422 Schisandra chinensis Nutrition 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 210000001744 T-lymphocyte Anatomy 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 210000003719 b-lymphocyte Anatomy 0.000 description 3
- 239000002775 capsule Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 239000003085 diluting agent Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000008588 hemolysis Effects 0.000 description 3
- 208000027866 inflammatory disease Diseases 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 229940124595 oriental medicine Drugs 0.000 description 3
- 239000008194 pharmaceutical composition Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000000829 suppository Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 239000003826 tablet Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 2
- WLNGPDPILFYWKF-OAHLLOKOSA-N (-)-beta-chamigrene Chemical compound C1CC(C)=CC[C@]21C(C)(C)CCCC2=C WLNGPDPILFYWKF-OAHLLOKOSA-N 0.000 description 2
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- JSNRRGGBADWTMC-UHFFFAOYSA-N (6E)-7,11-dimethyl-3-methylene-1,6,10-dodecatriene Chemical compound CC(C)=CCCC(C)=CCCC(=C)C=C JSNRRGGBADWTMC-UHFFFAOYSA-N 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
- FTOAOBMCPZCFFF-UHFFFAOYSA-N 5,5-diethylbarbituric acid Chemical compound CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 240000001810 Angelica gigas Species 0.000 description 2
- 235000018865 Angelica gigas Nutrition 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000283007 Cervus nippon Species 0.000 description 2
- 241000759833 Cornus officinalis Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- ZFMSMUAANRJZFM-UHFFFAOYSA-N Estragole Chemical compound COC1=CC=C(CC=C)C=C1 ZFMSMUAANRJZFM-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N Glycerol trihexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 2
- 240000002045 Guettarda speciosa Species 0.000 description 2
- 108010002352 Interleukin-1 Proteins 0.000 description 2
- 102000000589 Interleukin-1 Human genes 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241001494479 Pecora Species 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 244000299461 Theobroma cacao Species 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- HLXRWTJXGMHOFN-UHFFFAOYSA-N Verbenalin Natural products C12C(C)CC(=O)C2C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O HLXRWTJXGMHOFN-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 241000234299 Zingiberaceae Species 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 230000002391 anti-complement effect Effects 0.000 description 2
- 108010008730 anticomplement Proteins 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 235000011869 dried fruits Nutrition 0.000 description 2
- 239000003937 drug carrier Substances 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229930182494 ginsenoside Natural products 0.000 description 2
- 229940089161 ginsenoside Drugs 0.000 description 2
- TXEWRVNOAJOINC-UHFFFAOYSA-N ginsenoside Rb2 Natural products CC(=CCCC(OC1OC(COC2OCC(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C TXEWRVNOAJOINC-UHFFFAOYSA-N 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- VSMOENVRRABVKN-UHFFFAOYSA-N oct-1-en-3-ol Chemical compound CCCCCC(O)C=C VSMOENVRRABVKN-UHFFFAOYSA-N 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 108010001062 polysaccharide-K Proteins 0.000 description 2
- 229940034049 polysaccharide-k Drugs 0.000 description 2
- 239000000955 prescription drug Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 229930004725 sesquiterpene Natural products 0.000 description 2
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- 235000019614 sour taste Nutrition 0.000 description 2
- 229940063673 spermidine Drugs 0.000 description 2
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 235000012222 talc Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000008979 vitamin B4 Nutrition 0.000 description 2
- 239000011579 vitamin B4 Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 1
- CRPUJAZIXJMDBK-DTWKUNHWSA-N (+)-camphene Chemical compound C1C[C@@H]2C(=C)C(C)(C)[C@H]1C2 CRPUJAZIXJMDBK-DTWKUNHWSA-N 0.000 description 1
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 description 1
- WRHGORWNJGOVQY-KKUMJFAQSA-N (+)-gamma-cadinene Chemical compound C1CC(C)=C[C@H]2[C@H](C(C)C)CCC(=C)[C@@H]21 WRHGORWNJGOVQY-KKUMJFAQSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- UGJAEDFOKNAMQD-DVQDXYAYSA-N (-)-Falcarinol Natural products CCCCCCC\C=C\CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-DVQDXYAYSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- JXZQZARENYGJMK-CQSZACIVSA-N (-)-beta-Curcumene Natural products CC(C)=CCC[C@@H](C)C1=CCC(C)=CC1 JXZQZARENYGJMK-CQSZACIVSA-N 0.000 description 1
- VMYXUZSZMNBRCN-CQSZACIVSA-N (-)-α-curcumene Chemical compound CC(C)=CCC[C@@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-CQSZACIVSA-N 0.000 description 1
- PYXFVCFISTUSOO-HKUCOEKDSA-N (20S)-protopanaxadiol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@H]([C@@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C PYXFVCFISTUSOO-HKUCOEKDSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- UGJAEDFOKNAMQD-MQNTZWLQSA-N (3S,9Z)-1,9-Heptadecadiene-4,6-diyn-3-ol Chemical compound CCCCCCC\C=C/CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-MQNTZWLQSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- JSNRRGGBADWTMC-QINSGFPZSA-N (E)-beta-Farnesene Natural products CC(C)=CCC\C(C)=C/CCC(=C)C=C JSNRRGGBADWTMC-QINSGFPZSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- VSMOENVRRABVKN-MRVPVSSYSA-N 1-Octen-3-ol Natural products CCCCC[C@H](O)C=C VSMOENVRRABVKN-MRVPVSSYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- YDXQPTHHAPCTPP-UHFFFAOYSA-N 3-Octen-1-ol Natural products CCCCC=CCCO YDXQPTHHAPCTPP-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- PUQSUZTXKPLAPR-KSSYENDESA-N 4-(beta-D-Glucopyranosyloxy) benzyl alcohol Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-KSSYENDESA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 240000004510 Agastache rugosa Species 0.000 description 1
- 235000010686 Agastache rugosa Nutrition 0.000 description 1
- 241000208173 Apiaceae Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- PGTJIOWQJWHTJJ-CHWSQXEVSA-N Calamenene Chemical compound C1=C(C)C=C2[C@@H](C(C)C)CC[C@@H](C)C2=C1 PGTJIOWQJWHTJJ-CHWSQXEVSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- PTHCMJGKKRQCBF-UHFFFAOYSA-N Cellulose, microcrystalline Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC)C(CO)O1 PTHCMJGKKRQCBF-UHFFFAOYSA-N 0.000 description 1
- 240000000024 Cercis siliquastrum Species 0.000 description 1
- 241000283026 Cervus elaphus Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 241000555678 Citrus unshiu Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 241000142975 Cornaceae Species 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- 240000006563 Curcuma aeruginosa Species 0.000 description 1
- 241000963426 Curcuma chuanyujin Species 0.000 description 1
- 241000963421 Curcuma kwangsiensis Species 0.000 description 1
- 241000963390 Curcuma wenyujin Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 244000096857 Dioscorea batatas Species 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- UGJAEDFOKNAMQD-UHFFFAOYSA-N Falcarinol Natural products CCCCCCCC=CCC#CC#CC(O)C=C UGJAEDFOKNAMQD-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241000305491 Gastrodia elata Species 0.000 description 1
- PUQSUZTXKPLAPR-UJPOAAIJSA-N Gastrodin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(CO)C=C1 PUQSUZTXKPLAPR-UJPOAAIJSA-N 0.000 description 1
- 229930183217 Genin Natural products 0.000 description 1
- UFNDONGOJKNAES-UHFFFAOYSA-N Ginsenoside Rb1 Natural products CC(=CCCC(C)(OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CC(O)C45C)C UFNDONGOJKNAES-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 108090001005 Interleukin-6 Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- 241000218195 Lauraceae Species 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 241001532026 Liriope muscari Species 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000002791 Panax Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 102000016202 Proteolipids Human genes 0.000 description 1
- 108010010974 Proteolipids Proteins 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241001093501 Rutaceae Species 0.000 description 1
- 241000736078 Schisandra sphenanthera Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- MZOWOHKNFKJFFD-RRFJBIMHSA-N Sesquicarene Chemical compound C1CC(C)=C[C@H]2[C@@](CCC=C(C)C)(C)[C@H]21 MZOWOHKNFKJFFD-RRFJBIMHSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- FZPYMZUVXJUAQA-ZDUSSCGKSA-N Turmerone Chemical compound CC(C)=CC(=O)C[C@H](C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-ZDUSSCGKSA-N 0.000 description 1
- FZPYMZUVXJUAQA-UHFFFAOYSA-N Turmerone Natural products CC(C)=CC(=O)CC(C)C1=CCC(C)=CC1 FZPYMZUVXJUAQA-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 1
- VLXDPFLIRFYIME-MWHZVNNOSA-N alpha-Ylangene Chemical compound C1C=C(C)C2[C@@]3(C)CCC(C(C)C)C2C31 VLXDPFLIRFYIME-MWHZVNNOSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- XOCANRBEOZQNAQ-KBPBESRZSA-N alpha-turmerone Natural products O=C(/C=C(\C)/C)C[C@H](C)[C@H]1C=CC(C)=CC1 XOCANRBEOZQNAQ-KBPBESRZSA-N 0.000 description 1
- VLXDPFLIRFYIME-QRTUWBSPSA-N alpha-ylangene Natural products C1C=C(C)[C@@H]2[C@@]3(C)CC[C@@H](C(C)C)[C@@H]2[C@H]31 VLXDPFLIRFYIME-QRTUWBSPSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 229960002319 barbital Drugs 0.000 description 1
- HAVYZKHVTLAPDZ-RCHZWEEESA-N beta-Humulene Natural products C\C1=C\CC(C)(C)\C=C\CC(=C)CCC1 HAVYZKHVTLAPDZ-RCHZWEEESA-N 0.000 description 1
- YSNRTFFURISHOU-UHFFFAOYSA-N beta-farnesene Natural products C=CC(C)CCC=C(C)CCC=C(C)C YSNRTFFURISHOU-UHFFFAOYSA-N 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- QXMNTPFFZFYQAI-IMDKZJJXSA-N beta-sitosterol 3-O-beta-D-glucopyranoside Natural products CC[C@H](CC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@H](CC[C@]4(C)[C@H]3CC[C@]12C)O[C@@H]5C[C@H](CO)[C@@H](O)[C@H](O)[C@H]5O)C(C)C QXMNTPFFZFYQAI-IMDKZJJXSA-N 0.000 description 1
- PYXFVCFISTUSOO-UHFFFAOYSA-N betulafolienetriol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC(C(C)(O)CCC=C(C)C)C4C(O)CC3C21C PYXFVCFISTUSOO-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- JYTVKRNTTALBBZ-UHFFFAOYSA-N bis demethoxycurcumin Natural products C1=CC(O)=CC=C1C=CC(=O)CC(=O)C=CC1=CC=CC(O)=C1 JYTVKRNTTALBBZ-UHFFFAOYSA-N 0.000 description 1
- PREBVFJICNPEKM-YDWXAUTNSA-N bisdemethoxycurcumin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)CC(=O)\C=C\C1=CC=C(O)C=C1 PREBVFJICNPEKM-YDWXAUTNSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- PAYPBTPGBHRBLY-UHFFFAOYSA-N calamenene Natural products C1=CC(C)=CC2C(C(C)C)CCC(C)C21 PAYPBTPGBHRBLY-UHFFFAOYSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229940117948 caryophyllene Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- CNHRRMQBWQJRPN-UHFFFAOYSA-N chikusetsusaponin LM5 Natural products C1CC(C2(CC(O)C3C(C)(C)C(OC4C(C(O)C(O)C(CO)O4)OC4C(C(O)C(O)C(CO)O4)O)CCC3(C)C2CC2O)C)(C)C2C1C(C)(CCC=C(C)C)OC(C(C(O)C1O)O)OC1COC1OC(CO)C(O)C1O CNHRRMQBWQJRPN-UHFFFAOYSA-N 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 208000023819 chronic asthma Diseases 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- NPJICTMALKLTFW-OFUAXYCQSA-N daucosterol Chemical compound O([C@@H]1CC2=CC[C@H]3[C@@H]4CC[C@@H]([C@]4(CC[C@@H]3[C@@]2(C)CC1)C)[C@H](C)CC[C@@H](CC)C(C)C)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O NPJICTMALKLTFW-OFUAXYCQSA-N 0.000 description 1
- QDFKFNAHVGPRBL-UHFFFAOYSA-N daucosterol Natural products CCC(CCC(C)C1CCC2C1CCC3C2(C)CC=C4CC(CCC34C)OC5OC(CO)C(O)C(O)C5O)C(C)C QDFKFNAHVGPRBL-UHFFFAOYSA-N 0.000 description 1
- YOCDGWMCBBMMGJ-UHFFFAOYSA-N delta-cadinene Natural products C1C=C(C)CC2C(C(C)C)CCC(=C)C21 YOCDGWMCBBMMGJ-UHFFFAOYSA-N 0.000 description 1
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- YXAKCQIIROBKOP-UHFFFAOYSA-N di-p-hydroxycinnamoylmethane Natural products C=1C=C(O)C=CC=1C=CC(=O)C=C(O)C=CC1=CC=C(O)C=C1 YXAKCQIIROBKOP-UHFFFAOYSA-N 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229960003399 estrone Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 238000000684 flow cytometry Methods 0.000 description 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- JBHJOURGKXURIW-UHFFFAOYSA-N gamma-cadinene Natural products CC(C)C1CCC(=C2CCC(=C)CC12)C JBHJOURGKXURIW-UHFFFAOYSA-N 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- 229930193974 gastrodin Natural products 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- GZYPWOGIYAIIPV-JBDTYSNRSA-N ginsenoside Rb1 Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O GZYPWOGIYAIIPV-JBDTYSNRSA-N 0.000 description 1
- JDCPEKQWFDWQLI-LUQKBWBOSA-N ginsenoside Rc Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)O[C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)CC[C@]4(C)[C@H]3C[C@H]2O)C)(C)CC1)O[C@@H]1O[C@@H](CO)[C@H](O)[C@H]1O JDCPEKQWFDWQLI-LUQKBWBOSA-N 0.000 description 1
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 1
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 1
- SPFXZQZPHXUJSR-UHFFFAOYSA-N ginsenoside-Rc Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1OC2OC(CO)C(O)C2O)C3CCC4(C)C3C(O)CC5C6(C)CCC(OC7OC(CO)C(O)C(O)C7OC8OC(CO)C(O)C(O)C8O)C(C)(C)C6CCC45C)C SPFXZQZPHXUJSR-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- PUQSUZTXKPLAPR-NZEXEKPDSA-N helicidol Natural products O([C@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](CO)O1)c1ccc(CO)cc1 PUQSUZTXKPLAPR-NZEXEKPDSA-N 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 239000006049 herbal material Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 238000001794 hormone therapy Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000000367 immunologic factor Substances 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 239000000077 insect repellent Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- VMPHSYLJUKZBJJ-UHFFFAOYSA-N lauric acid triglyceride Natural products CCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC VMPHSYLJUKZBJJ-UHFFFAOYSA-N 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 210000005210 lymphoid organ Anatomy 0.000 description 1
- 229960003511 macrogol Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Chemical compound CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000011164 ossification Effects 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- KKAHGGJBKUXDNQ-KRWDZBQOSA-N panaxynol Natural products CCCCCCCC=CC=CCC#C[C@@H](O)C=C KKAHGGJBKUXDNQ-KRWDZBQOSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- SWQINCWATANGKN-UHFFFAOYSA-N protopanaxadiol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC1C3(C)CCC(O)C(C)(C)C3CCC21C SWQINCWATANGKN-UHFFFAOYSA-N 0.000 description 1
- SHCBCKBYTHZQGZ-DLHMIPLTSA-N protopanaxatriol Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2[C@@H](O)C[C@@]3(C)[C@]4(C)CC[C@H]([C@](C)(O)CCC=C(C)C)[C@H]4[C@H](O)C[C@@H]3[C@]21C SHCBCKBYTHZQGZ-DLHMIPLTSA-N 0.000 description 1
- BBEUDPAEKGPXDG-UHFFFAOYSA-N protopanaxatriol Natural products CC(CCC=C(C)C)C1CCC2(C)C1C(O)CC3C4(C)CCC(O)C(C)(C)C4C(O)CC23C BBEUDPAEKGPXDG-UHFFFAOYSA-N 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- MZOWOHKNFKJFFD-UHFFFAOYSA-N rac-Sesquicaren Natural products C1CC(C)=CC2C(CCC=C(C)C)(C)C21 MZOWOHKNFKJFFD-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 229930013921 sesquicarene Natural products 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940063675 spermine Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- PGTJIOWQJWHTJJ-UHFFFAOYSA-N trans-Calamenene Natural products C1=C(C)C=C2C(C(C)C)CCC(C)C2=C1 PGTJIOWQJWHTJJ-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- HAVYZKHVTLAPDZ-PRUKLFJYSA-N β-humulene Chemical compound C\C1=C\CC(C)(C)\C=C/CC(=C)CCC1 HAVYZKHVTLAPDZ-PRUKLFJYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Polymers & Plastics (AREA)
- Gastroenterology & Hepatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 면역증강용 조성물에 관한 것으로, 더욱 상세하게는 녹용, 당귀, 산수유, 구기자, 울금, 산약, 진피, 배초향, 천마, 계피, 오미자, 홍삼, 맥문동 및 감귤분말의 추출물을 적정 성분비로 포함하여 면역증강, 체력증진 및 피로회복 등의 공진단과 유사한 약리활성을 나타내 사향이 제거된 가미공진단 제조에 이용하거나, 면역증강 및 피로회복을 위한 약학적 제제 또는 건강기능식품으로 이용가능한 면역증강용 조성물에 관한 것이다. 특히, 본 발명에 따른 면역증강용 조성물은 환제로 제조시 그 맛이 새콤달콤하여 취식성이 증대되므로 성장기 어린이나 청소년을 위한 제제로 유용하게 이용될 수 있다.The present invention relates to a composition for enhancing immunity, and more particularly, it contains extracts of antler, angelica, cornflower oil, goji berry, turmeric, sanyak, dermis, baechohyang, cheonma, cinnamon, omija, red ginseng, maekmundong, and citrus powder in appropriate ingredient ratios. Thus, it exhibits pharmacological activity similar to that of ginseng ginseng such as immunity enhancement, physical strength improvement and fatigue recovery, and can be used for manufacturing gamigong ginseng from which musk has been removed, or as a pharmaceutical preparation or health functional food for immune enhancement and fatigue recovery. is about In particular, the composition for enhancing immunity according to the present invention can be usefully used as a preparation for growing children or adolescents because the taste is sweet and sour and edible is increased when prepared as a pill.
Description
본 발명은 한약재를 주재료로 하는 면역증강용 조성물에 관한 것으로, 더욱 상세하게는 녹용, 당귀, 산수유, 구기자, 울금, 산약, 진피, 배초향, 천마, 계피, 오미자, 홍삼, 맥문동 및 감귤분말의 추출물을 적정 성분비로 포함하여 면역증강, 체력증진 및 피로회복 등의 공진단과 유사한 약리활성을 나타내 사향이 제거된 가미공진단 제조에 이용하거나, 면역증강 및 피로회복을 위한 약학적 제제 또는 건강기능식품으로 이용가능한 면역증강용 조성물에 관한 것이다.The present invention relates to an immune-enhancing composition containing herbal medicines as main ingredients, and more particularly, extracts of antler, angelica, cornflower, goji berry, turmeric, sanyak, dermis, baechohyang, cheonma, cinnamon, omija, red ginseng, maekmundong and citrus powder. It contains pharmacological activity similar to Gongjindan such as immunity enhancement, physical strength improvement and fatigue recovery by including it in an appropriate ingredient ratio, so it is used for manufacturing Gamigonginseng from which musk has been removed, or as a pharmaceutical preparation or health functional food for immunity enhancement and fatigue recovery. It relates to a possible composition for enhancing immunity.
최근 산업화와 환경의 변화 속에서 현대인들은 다양한 원인에 의한 면역력 저하로 인해 각종 질병에 노출되어 있으며, 이러한 질병 치료를 위해 막대한 비용을 소모하고 있다. 특히, 최근 오염된 공기 및 신생활 변화, 즉, 인스턴트 식품, 탄산음료 등의 과잉섭취 등으로 인해 면역체계에 이상이 발생하여 알러지성 질환들이 지속적으로 증가되고 있는 추세이다. 알러지성 질환은 여러 알러지 유발인자에 의해 인체 면역체계를 과도하게 항진시켜 대식세포와 같은 면역세포에서 TNF-α(tumor necrosis factor-α), IL-1(interleukin-1), IL-6(interleukin-6), 프로스타글란딘(prostagladin), 류코트리엔(luecotriene) 및 산화질소(nitric oxide, NO)와 같은 염증유발물질을 과도하게 유도하여 이는 염증반응으로 진행되어 알러지성 비염, 아토피성 피부염, 만성 천식 및 면역 과민반응 증상 등을 일으키는 것으로 알려져 있다.In recent years of industrialization and changes in the environment, modern people are exposed to various diseases due to reduced immunity due to various causes, and consume a huge amount of money to treat these diseases. In particular, due to recent changes in polluted air and new lifestyles, that is, excessive consumption of instant food and carbonated drinks, etc., abnormalities in the immune system occur, and allergic diseases are continuously increasing. Allergic diseases are caused by excessive stimulation of the human immune system by several allergens, so that TNF-α (tumor necrosis factor-α), IL-1 (interleukin-1), IL-6 (interleukin) -6), prostaglandin (prostagladin), leukotriene (luecotriene), and nitric oxide (NO) by inducing an excessive amount of inflammatory substances such as nitric oxide (NO), which progresses to an inflammatory reaction allergic rhinitis, atopic dermatitis, chronic asthma and immunity It is known to cause hypersensitivity reactions.
이러한 면역질환을 예방 및 치료하기 위해, 여러 가지 약제가 개발되고 있으나, 대부분의 약제들이 화학약품들로 부작용이 있으며, 지속적인 치료효과를 내지 못하는 한계가 있었다.In order to prevent and treat these immune diseases, various drugs have been developed, but most drugs are chemical drugs and have side effects, and there is a limitation in not being able to provide a continuous therapeutic effect.
한의학에서는 질병이 야기되기 이전에 예방하는 예방치료의 개념이 강하였으며, 종래의 보약이 이러한 개념이었다. 이러한 보약들의 대표적인 한의학적 처방약인 공진단은 녹용, 당귀, 산수유, 사향으로 구성된 처방으로 공진단의 활용을 살펴보면 노화를 방지하고 질병을 예방하는 경우, 수술이나 큰 병으로 원기가 쇠약해진 경우, 정신적 신체적 과로로 기력이 저하된 경우, 만성 피로가 심하여 휴식으로도 회복이 더딘 경우, 선천적으로 체질이 약한 경우, 혈액순환 저하로 몸이 무겁고 저린 경우, 신경이 예민하여 어지럼증과 불면증이 있는 경우, 과다한 스트레스와 음주로 간 기능이 약화된 경우 등에 유용하다고 알려져 있다. 동의보감에는 “대체로 남자가 장년시기에 진기(眞氣)가 몹시 약한 것은 타고날 때부터 약하고 허한 것이 아니므로 성질이 조(燥)한 약재를 쓰지 말아야 한다. 음혈을 보한다고 하는 처방들에 약품은 많으나 약효가 매우 약하여 효력을 보기 어렵다. 다만 타고난 원기를 든든히 하여 신수와 심화가 잘 오르내리게 되면 오장이 스스로 조화되고 온갖 병이 생기지 않을 것이다. 이런 때에는 이 처방을 쓴다.”라고 되어 있고 녹용(졸인 젖을 발라 구운 것), 당귀, 산수유 각각 160g, 사향(따로 간 것) 20g을 가루 내어 술을 두고 쑨 밀가루풀로 반죽한 다음 벽오동씨 만하게 알약을 만들어 한번에 70-100알씩 데운 술이나 소금 끓인 물로 복용하게 되어 있다.In oriental medicine, the concept of preventive treatment to prevent disease before it occurs was strong, and conventional herbal medicine was such a concept. Gongjindan, a representative oriental medicine prescription drug for these supplements, is a prescription composed of antler, angelicae, cornflower oil, and musk. If you look at the use of Gongjindan to prevent aging and disease, if your energy is weakened due to surgery or a serious illness, or if you are mentally or physically overworked Low energy, severe chronic fatigue, slow recovery even with rest, congenital weakness, weight and numbness due to decreased blood circulation, dizziness and insomnia due to sensitive nerves, excessive stress and drinking It is known to be useful when the liver function is weakened. According to Donguibogam, “In general, when a man has very weak energy in his adulthood, he is not born weak and vain. There are many drugs in the prescriptions to protect eumhyeol, but the efficacy is very weak, so it is difficult to see the effect. However, if the innate vitality is strengthened and the divine beast and shiver go up and down well, the five organs will harmonize themselves and all kinds of diseases will not occur. In such a case, I use this recipe.” Grind antler (baked in boiled milk), 160g each of Angelica keis, and cornsuis oil, and 20g of musk (separately ground), add alcohol, knead it with Sun wheat paste, and then take a pill the size of a Byeok Paulownia seed. 70-100 tablets at a time are to be taken with boiled alcohol or salted water.
그러나, 공진단의 주요성분 중 하나인 사향은 원료에 대한 공급이 원활하지 못하고 가격 또한 고가이며 진위에 대한 논란이 심하여 사용상의 문제가 있어 왔다. 또한, 최근에 사향의 대체품으로 사용하고 있는 목향은 의약품으로는 사용이 가능하지만 식품으로 개발할 수 없는 단점이 있다.However, musk, which is one of the main ingredients of Gongjindan, has had problems in using it because the supply of raw materials is not smooth, the price is also high, and there is a lot of controversy over its authenticity. In addition, although woodhyang, which has been recently used as a substitute for musk, can be used as a medicine, it has the disadvantage that it cannot be developed as a food product.
또한, 이러한 한약재를 주성분으로 하여 제조되는 공진단 등의 환제는 대부분 맛이 쓰게 되어 어린이나 청소년들이 취식하기 어려운 점이 있었다.In addition, most of the pills such as Gongjingin manufactured with these herbal ingredients as the main ingredient have a bitter taste, making it difficult for children and adolescents to eat them.
이에, 본 발명자는 사향을 제외하면서도, 기존의 공진단과 유사한 약리 효과를 갖는 새로운 배합의 생약 조성물을 개발하기 위해, 연구를 거듭한 결과, 녹용, 당귀, 산수유, 구기자, 울금, 산약, 진피, 배초향, 천마, 계피, 오미자, 홍삼, 맥문동 및 감귤분말의 추출물을 적정 성분비로 포함하는 조성물이 면역력 증진 및 피로회복 등의 효능을 나타내며, 환제로 제조시 식감이 우수하여 새로운 배합의 가미공진단으로 이용할 수 있음을 발견함으로써, 본 발명을 완성하였다.Accordingly, the present inventors conducted repeated research to develop a new formulation of a herbal composition having a pharmacological effect similar to that of the existing Gongjinjin, while excluding musk. , cinnamon, omija, red ginseng, maekmundong, and tangerine powder extracts in an appropriate ingredient ratio show effects such as immunity enhancement and fatigue recovery. By finding that there is, the present invention was completed.
따라서, 본 발명의 목적은 녹용, 당귀, 산수유, 구기자, 울금, 산약, 진피, 배초향, 천마, 계피, 오미자, 홍삼, 맥문동 및 감귤분말의 추출물을 유효성분으로 포함하는 면역증강용 조성물을 제공하는 것이다.Accordingly, an object of the present invention is to provide a composition for enhancing immunity comprising extracts of antler, angelica, cornflower oil, goji berry, turmeric, sanyak, dermis, baechohyang, cheonma, cinnamon, omija, red ginseng, maekmundong and citrus powder as active ingredients will be.
본 발명의 다른 목적은 상기 조성물과 약제학적으로 허용가능한 담체를 포함하는, 면역질환 예방 또는 치료용 약학적 제제를 제공하는 것이다.Another object of the present invention is to provide a pharmaceutical preparation for preventing or treating immune diseases, comprising the composition and a pharmaceutically acceptable carrier.
본 발명의 또 다른 목적은 상기 조성물을 포함하는 면역질환 개선 및 피로회복 증진용 건강기능식품을 제공하는 것이다.Another object of the present invention is to provide a health functional food for improving immune disease and improving fatigue recovery comprising the composition.
하나의 양태로서, 본 발명은 녹용, 당귀, 산수유, 구기자, 울금, 산약, 진피, 배초향, 천마, 계피, 오미자, 홍삼, 맥문동 및 감귤분말의 추출물을 유효성분으로 포함하는 면역증강용 조성물에 관한 것이다.In one aspect, the present invention relates to a composition for enhancing immunity comprising an extract of antler, angelica, cornflower oil, goji berry, turmeric, sanyak, dermis, baechohyang, cheonma, cinnamon, omija, red ginseng, maekmundong and citrus powder as active ingredients will be.
본 발명의 조성물에 포함되는 각 생약 재료들은 재배한 것 또는 시판되는 것 등을 제한 없이 사용할 수 있으며, 상기 추출물을 제조하는 방법은 당업계의 통상적인 추출방법을 사용할 수 있다. 구체적으로, 건조, 동결 상태 또는 자연 그대로의 재료들을 적절히 세절하여 건조중량의 약 1 내지 15배, 바람직하게는 약 10 내지 15배 부피의 정제수(물), 탄소수 1 내지 4의 저급 알코올 또는 이들의 혼합용매를 사용하여 추출할 수 있다. 추출 방법은 열수 추출, 냉침 추출, 환류 냉각 추출 또는 초음파 추출 등을 이용할 수 있으며, 바람직하게는 열수 추출한다.Each herbal material included in the composition of the present invention can be used without limitation, such as cultivated or commercially available, and a conventional extraction method in the art can be used for the preparation of the extract. Specifically, by appropriately shredding dried, frozen or natural materials, purified water (water), lower alcohols having 1 to 4 carbon atoms, or their It can be extracted using a mixed solvent. As the extraction method, hot water extraction, cold extraction, reflux cooling extraction, ultrasonic extraction, or the like may be used, preferably hot water extraction.
또한, 상기 추출물을 정제 및 농축하기 위해 여과하여 동결건조하여 사용할 수 있다.In addition, in order to purify and concentrate the extract, it may be used after filtration and freeze-drying.
본 발명의 조성물에 포함되는 녹용은 사슴과(鹿科;Cervidae)에 속한 매화록(梅花鹿) Cervus nippon Temminck, 마록(馬鹿) C. elaphus Linne 또는 대록(大鹿) C. canadensis Erxleben의 숫사슴의 털이 밀생하고 아직 골질화되지 않았거나 약간 골질화 된 어린 뿔을 자른 다음 말린 것이다. 녹용에는 16 종류의 아미노산이 함유되어 있는데, 그 중에서 proline, lysine, serine의 함량이 가장 높은 것으로 알려져 있다. 녹용의 상대에는 amine류가 다량 함유되어 있는데 그 중에서 spermine, spermidine, putrescine이 풍부하다. 녹용의 중대와 하대에는 골화가 많이 진행된 상태이며 spermidine의 함량이 감소되어 있다. 이외에도 collagen, estrone, proteolipid 등이 함유되어 있다.The deer antler contained in the composition of the present invention is a deer hair of Cervus nippon Temminck, Cervus nippon Temminck, C. elaphus Linne, or Daerok C. canadensis Erxleben belonging to the family Cervidae. Dense, not yet ossified, or slightly ossified young horns are cut and dried. Deer antler contains 16 kinds of amino acids, and among them, proline, lysine, and serine are known to have the highest content. Deer antlers contain a large amount of amines, among which spermine, spermidine, and putrescine are abundant. In the middle and lower antlers, ossification has progressed a lot and the content of spermidine is decreased. In addition, it contains collagen, estrone, proteolipid, etc.
당귀는 미나리과(形科:Umbelliferae)에 속한 다년생 초본인 당귀 참당귀 Angelica gigas Nakai의 뿌리를 건조시킨 것이다. 방향성분인 정유 및 데쿠신, 진정작용하는 베타시토스테롤, 자당, 니코틴산, 엽산 등의 성분으로 구성되어 있다.Angelica gigas Nakai is a dried root of Angelica gigas Nakai, a perennial herb belonging to the Umbelliferae family. It consists of essential oil and decucin, which are aromatic ingredients, beta-sitosterol, sucrose, nicotinic acid, and folic acid, which have a calming effect.
산수유는 층층나무과(山茶萸科:Cornaceae)에 속한 낙엽소교목인 산수유나무 Cornus officinalis Sieb. et. Zucc.의 성숙한 열매를 건조한 것으로, 果肉에는 cornin, 즉 verbenalin, saponin, tannin, ursolic acid 및 vitamin A가 함유되어 있고, 종자의 지방유에는 palmitin acid, olein acid, linol acid 등이 함유되어 있다.Cornus officinalis Sieb, a deciduous small tree belonging to the Cornaceae family, Cornus officinalis Sieb. et. It is the dried fruit of Zucc., and it contains cornin, that is, verbenalin, saponin, tannin, ursolic acid and vitamin A, and the oil of the seed contains palmitin acid, olein acid, linol acid, etc.
구기자는 가지과(茄科:Solanaceae)에 속한 구기자나무 Lycium chinense Mill. 또는 기타 동속식물의 성숙한 과실로, Carotene 3.39㎎%, vitamin B1 0.23㎎%, vitamin B2 0.33㎎%, nicotin acid 1.7㎎%, vitamin C 3㎎%을 함유하고, β-sitosterol, linoleic acid등이 함유되어 있다.Lycium chinense Mill belongs to the Solanaceae family. Or other mature fruits of plants and animals, containing Carotene 3.39mg%, vitamin B1 0.23mg%, vitamin B2 0.33mg%, nicotin acid 1.7mg%, vitamin C 3mg%, β-sitosterol, linoleic acid, etc. has been
울금은 생강과(生薑科;Zingiberaceae)에 속한 鬱金 Curcuma aromatica Salisb. 또는 溫鬱金 C. wenyujin Y.H. Chen et C. Ling, 薑黃 C. longa L. 廣西莪朮 C. kwangsiensis S. Lee et C. F. Liang, 我朮 C.aeruginosa Roxb. 川鬱金 C. chuanyujin C. K. Hsieh et H. Zhang의 塊根을 건조한 것으로, 주성분으로는 精油 6.1%가 함유되어 있는데, 그 중에는 d-camphene 0.8%, d-camphor 2.5%, sesquiterpene(l-α-curcumene, l-β-curcumene) 65.5%, sesqui-terpene alcohol 22% 등이 들어 있고, 또 curcumin 0.3%, demethoxycurcumine, bisdemethoxycurcumin, turmerone, arturmerone 등도 들어 있다. 그 작용은 강황과 유사하다. 그밖에 澱粉 30~40%, 脂肪油 3%, 黃色色素와 carvone 및 phellandrene이 들어 있다.Turmeric belongs to the ginger family (生薑科; Zingiberaceae). or 溫鬱金 C. wenyujin Y.H. Chen et C. Ling, 薑黃 C. longa L. 廣西莪朮 C. kwangsiensis S. Lee et C. F. Liang, 我朮 C.aeruginosa Roxb. It is a dried saffron from C. chuanyujin C. K. Hsieh et H. Zhang, and the main component contains 6.1% of mulberry, among which 0.8% of d-camphene, 2.5% of d-camphor, and sesquiterpene (l-α-curcumene, l-β-curcumene) 65.5%, sesqui-terpene alcohol 22%, etc., and curcumin 0.3%, demethoxycurcumine, bisdemethoxycurcumin, turmerone, arturmerone, etc. Its action is similar to that of turmeric. In addition, 澱粉 30-40%, 脂肪油 3%, 黃色色素 and carvone and phellandrene are contained.
산약은 마과(薯科:Dioscoreaceae)에 속한 마 Dioscorea batatas Decne.(=D. opposita Thunb.)와 참마 D.japonica Thunb.의 껍질을 제거한 뿌리줄기 Saponin, 점액, cholin, 전분(16%), glycoprotein과 유리amino산을 함유하며, 또한 abscisin Ⅱ, polyphenol 산화효소, vitamin C(5mg%), 3,4-dihydroxy-phenylethylamine(dopamine)을 함유하고 점액 중에는 mannan과 phytin산이 함유되어 있다.Saponin, mucus, cholin, starch (16%), glycoprotein from the rhizomes of the hemp Dioscorea batatas Decne. and free amino acids, abscisin Ⅱ, polyphenol oxidase, vitamin C (5mg%), 3,4-dihydroxy-phenylethylamine (dopamine), and mannan and phytinic acid in the mucus.
진피는 운향과(芸香科:Rutaceae)에 속한 귤나무(橘) Citrus unshiu Markovich (=Citrus reticulata Blanco) 및 동속 근연식물의 성숙한 과실의 과피로 성분 중 정유성분으로 주성분은 d-limonine이며 이 외에도 hesperidin, myoinositol, vitamin C 등이 함유되어 있고 또한 flavonoide 배당체가 많이 함유되어 있다.The dermis is the rind of the mature fruit of Citrus unshiu Markovich (= Citrus reticulata Blanco) belonging to the Rutaceae family and a related plant. , myoinositol, and vitamin C, and also contains a lot of flavonoide glycosides.
곽향은 꿀풀과(脣形科:Labiatae)에 속한 배초향(藿香) Agastache rugosa (Fisch. et Meyer) O. Kuntze의 전초의 지상부로 6~7月 사이에 채취하여 햇볕에 말리거나 음건한다. 곽향에는 정유 0.28%를 함유되어 있으며, 주성분으로 methylchavicol이 80% 이상을 차지하고, anethole, anisaldehydel, α-limonene, ρ-metlioxycinnaldehyde, α-pinene, β-pinene, 3-ocatanone, 3-ocatanol, ρ-cymene, 1-octen-3-ol, linalool, 1-caryophyllene, β-elemen, β-humulene, β-farnesene, γ-cadinene, calamenene 등이 함유되어 있다.Kwakhyang is the above-ground part of the outpost of Agastache rugosa (Fisch. et Meyer) O. Kuntze belonging to the Lamiaceae family, Labiatae. It is collected between June and July and dried in the sun or shaded. Kwakhyang contains 0.28% of essential oil, and methylchavicol as the main component accounts for more than 80%, anethole, anisaldehydel, α-limonene, ρ-metlioxycinnaldehyde, α-pinene, β-pinene, 3-ocatanone, 3-ocatanol, ρ- It contains cymene, 1-octen-3-ol, linalool, 1-caryophyllene, β-elemen, β-humulene, β-farnesene, γ-cadinene, and calamenene.
천마는 난초과(蘭科:Orchidaceae)에 속한 천마 Gastrodia elata Bl.의 덩이뿌리를 건조한 것으로 Gastrodin, gastrodioside(p-hydroxybenzol), vanillyl alcohol, succinic acid, citric acid, palmitic acid, p-hydroxybenzaldehyde, 미량의 alkaloids 등을 함유하고 있다. 주성분으로 알려진 gastrodin함량은 산지에 따라 차이가 있으나 약 0.25~0.67% 정도이다.Chunma is the dried tuber root of Gastrodia elata Bl. belonging to the Orchidaceae family. contains etc. The gastrodin content, known as the main component, varies depending on the production area, but it is about 0.25 to 0.67%.
계피는 녹나무과(樟科:Lauraceae)에 속한 육계 Cinnamomum cassia Presl의 수피로 정유성분이 1~2% 함유되어 있는데, 그 주성분은 cinnamaldehyde가 75~90%이다. 성질은 뜨겁고 맛은 맥고 달다.Cinnamon is the bark of the broiler Cinnamomum cassia Presl belonging to the Lauraceae family, and contains 1~2% of essential oil, and its main component is 75~90% of cinnamaldehyde. It is hot in nature and has a bitter and sweet taste.
오미자는 오미자과(Schisandraceae)에 속한 오미자(북오미자) Schisandra chinensis Baill. 또는 화중오미자(남오미자) S. sphenanthera Rehd. et Wils.의 완숙한 과실을 건조한 것으로, 정유 약 3%가 함유되어 있으며, 정유 속에 다양의 sesquicarene, β2 -bisabclene, β-chamigrene, α-ylangene 등이 함유되어 있다.Schisandra chinensis Baill. Schisandra chinensis Baill. or S. sphenanthera Rehd. et Wils. et Wils. contains about 3% of essential oil, and various sesquicarene, β2-bisabclene, β-chamigrene, α-ylangene, etc. are contained in the essential oil.
건조된 과실은 citral 12%, 사과산 10% 및 소량의 주석산을 함유하고 그 밖에 과당, 수지 등이 함유되어 있다.Dried fruit contains 12% citral, 10% malic acid, and a small amount of tartaric acid, as well as fructose and resin.
인삼은 두릅나무과(五加科:Araliaceae)에 속한 인삼 Panax ginseng C.A Mey의 뿌리를 가공한 것으로, 가을에 줄기와 잎이 마를 때 캐어 말린 것을 백삼이라 하고, 잔뿌리를 제거하고 쪄서 건조한 것을 홍삼이라 하며 설탕에 가공하여 건조한 것을 당삼이라 한다. 인삼에는 ginsenoside가 약 5.22% 함유되어 있다. 인삼 ginsenoside는 13종 이상의 saponin혼합물이며, 그 가운데에서 ginsenoside Rb1, Rc 및 Rg1의 함유량이 비교적 높다.Ginseng is a processed ginseng root of Panax ginseng C.A Mey belonging to the Araliaceae family. When the stem and leaves are dry in autumn, it is called white ginseng, and it is called white ginseng, and the fine root is removed and steamed and dried. Dried ginseng after processing with sugar is called sugar ginseng. Ginseng contains about 5.22% of ginsenoside. Ginseng ginsenoside is a mixture of more than 13 kinds of saponin, and among them, the content of ginsenoside Rb1, Rc and Rg1 is relatively high.
saponin이 함유된 genin은 protopanaxadiol, protopanaxatriol, oleanol acid의 3종이 있다. 또한 정유가 약0.05% 함유되어 있는데 여기에는 독특한 향기의 근원이 되는 β-elemen과 쉽게 수지로 변하는 panaxynol이 함유되어 있다. 또한 panax acid는 palmitin acid, stearin acid, olein acid, linol acid 등의 혼합물인데 뿌리에 함유되어 있는 지질의 가수분해에 의하여 생성된 것이다. 또 β-sitosterol, stigmasterol 및 campesterol과 daucosterol도 분리되었으며, cholin이 0.1~0.2% 함유되어 있는데 이것이 인삼의 강압성분이다. 또 많은 종류의 amino acid와 peptide류, vitamin AㆍBlㆍB2ㆍC 등과 포도당, 과당, 맥아당, 자당 등이 함유되어 있다.There are three types of genin containing saponin: protopanaxadiol, protopanaxatriol, and oleanol acid. In addition, it contains about 0.05% of essential oil, which contains β-elemen, which is the source of a unique fragrance, and panaxynol, which easily turns into resin. In addition, panax acid is a mixture of palmitin acid, stearin acid, olein acid, linol acid, etc., and is produced by hydrolysis of lipids contained in roots. In addition, β-sitosterol, stigmasterol, campesterol, and daucosterol were also isolated, and cholin was contained in 0.1~0.2%, which is a potentiating component of ginseng. It also contains many kinds of amino acids and peptides, vitamins A·Bl·B2·C, and glucose, fructose, maltose, and sucrose.
맥문동은 백합과(百合科:Liliaceae)에 속한 맥문동 Liriope platyphylla Wang et Tang 또는 소엽맥문동 Ophiopogon japonicus Ker-Gawl. 의 塊根으로, 주요성분으로는 Glucose, fructose 등의 당류와 sucrose β-sitosterol, β-sitosterol-β-D-glucose및 기타 점액질을 함유한다. 최근에 와서 steroid, saponin 인 pohiopogonin A·B·C·D와 oligosaccharide가 발견되었다.Liriope platyphylla Wang et Tang or Ophiopogon japonicus Ker-Gawl belonging to the family Liliaceae. It contains sugars such as glucose and fructose, sucrose β-sitosterol, β-sitosterol-β-D-glucose and other mucilage as main components. Recently, steroids, saponins, pohiopogonin A, B, C, D, and oligosaccharides were discovered.
본 발명의 면역증강용 조성물에 포함되는 각 구성성분의 함량은 녹용 5~25질량비, 당귀 5~25질량비, 산수유5~25질량비, 구기자 5~25질량비, 울금 5~15질량비, 산약 5~15질량비, 진피 5~15질량비, 배초향 5~15질량비, 천마 1~5질량비, 계피 1~5질량비, 오미자 1~5질량비, 홍삼 1~5질량비, 맥문동 1~5질량비 및 감귤분말 1~5질량비로 포함할 수 있으며, 바람직하게는 녹용 10~15질량비, 당귀 10~15질량비, 산수유 10~15질량비, 구기자 10~15질량비, 울금 8~12질량비, 산약 8~12질량비, 진피 8~12질량비, 배초향 8~12질량비, 천마 1~4질량비, 계피 1~4질량비, 오미자 1~4질량비, 홍삼 1~4질량비, 맥문동 1~4질량비 및 감귤분말 1~4질량비로 포함하고, 더욱 바람직하게는 녹용 12질량비, 당귀 12질량비, 산수유 12질량비, 구기자 12질량비, 울금 10질량비, 산약 10질량비, 진피 10질량비, 배초향 10질량비, 천마 2질량비, 계피 2질량비, 오미자 2질량비, 홍삼 2질량비, 맥문동 2질량비 및 감귤분말 2질량비로 포함한다.The content of each component contained in the composition for enhancing immunity of the present invention is antler 5-25 mass ratio, angelica 5-25 mass ratio, cornflower oil 5-25 mass ratio, goji berry 5-25 mass ratio, turmeric 5-15 mass ratio, sanyak 5-15 Mass ratio, dermis 5-15 mass ratio, baechohyang 5-15 mass ratio, cheonma 1-5 mass ratio, cinnamon 1-5 mass ratio, omija 1-5 mass ratio, red ginseng 1-5 mass ratio, maekmundong 1-5 mass ratio, and citrus powder 1-5 mass ratio It may include, and preferably, antler 10-15 mass ratio, Angelica 10-15 mass ratio, cornflower oil 10-15 mass ratio, Goji berry 10-15 mass ratio, turmeric 8-12 mass ratio, acid about 8-12 mass ratio, dermis 8-12 mass ratio , Baechohyang 8-12 mass ratio, Chunma 1-4 mass ratio, cinnamon 1-4 mass ratio, Schisandra 1-4 mass ratio, red ginseng 1-4 mass ratio, Maekmundong 1-4 mass ratio and citrus powder 1-4 mass ratio, more preferably is antler 12 mass ratio, angelica 12 mass ratio, cornflower oil 12 mass ratio, goji berry 12 mass ratio, turmeric 10 mass ratio, ginseng 10 mass ratio, dermis 10 mass ratio, baechohyang 10 mass ratio, cheonma 2 mass ratio, cinnamon 2 mass ratio, omija 2 mass ratio, red ginseng 2 mass ratio, maekmundong It contains 2 mass ratio and 2 mass ratio of citrus powder.
본 발명의 면역증강용 조성물은 상기한 구성성분비를 가질 때, 세포독성을 나타내지 않으면서도 최적의 면역력 증강 효능을 나타낸다. 또한, 본 발명의 조성물이 환제 형태로 제공될 때, 상기한 구성성분비를 가지는 경우 식감이 우수하여 취식성이 높은 특징을 가진다.When the composition for enhancing immunity of the present invention has the above-described component ratio, it exhibits optimal immunity enhancing efficacy without exhibiting cytotoxicity. In addition, when the composition of the present invention is provided in the form of a pill, when it has the above-mentioned composition ratio, it has excellent texture and high edibility.
또한, 본 발명의 면역증강용 조성물은 면역증진과 체력증진, 스트레스 해소 작용을 가짐을 특징으로 한다.In addition, the composition for enhancing immunity of the present invention is characterized in that it has an effect of enhancing immunity, enhancing physical strength, and relieving stress.
본 발명의 면역증강용 조성물은 대표적인 한의학 처방약인 공진단의 주요구성성분으로 알려진 녹용, 산수유 및 당귀를 포함하면서, 다른 약재들, 구기자, 울금, 산약, 진피, 배초향, 천마, 계피, 오미자, 홍삼, 맥문동 및 감귤분말을 적정 비율로 포함함으로써, 면역증강 작용을 나타내므로, 사향이 제외된 가미공진단 제조에 이용될 수 있다. 따라서, 본 발명의 상기 조성물은 특히 환제 형태로 가공되는 것이 바람직하다. 이러한 환제 형태는 생약을 추출하여 농축한 후 각 약재를 분쇄기를 이용하여 극세말하여 추출물과 가루를 혼합하고, 약액과 혼합한 가루는 다시 분쇄기에 넣어 극세말을 하여 300 내지 500mesh의 체에 걸러내 미세한 입자로 만들어 꿀과 함께 환(丸) 또는 단(丹), 원(元) 등으로 제조할 수 있다. 이때, 복용의 편의성을 위해 3.75 ~ 6g 단위로 제작하여, 하루에 한 알 내지 두 알 섭취하게 할 수 있다. 또한, 환ㆍ단ㆍ원으로 만든 약재는 다시 식용 금박(또는 은박)을 사용하여 포장을 할 수 있다. 금 또는 은은 예로부터 환약을 만들 때 사용되어 마음을 안정시키고 방충 방부의 효과로 공진단이나 우황청심원 같은 처방에 보조재료로 이용하여 왔다. 또한, 다른 형태로는 환을 만드는 과정은 동일하게 하고 과거부터 염료로 사용해왔고 방충 방부의 효과가 있는 약재를 추출하여 표면에 코팅하여 사용할 수 있으며, 바람직하게는 자초 및 단삼 등의 한약재를 추출하여 천연 코팅할 수 있다. 본 발명의 면역증강용 조성물로 제조된 환제는 그 맛이 새콤달콤하여 취식성이 증대되므로, 성인뿐만 아니라, 어린이 및 청소년을 위한 제제로 이용될 수 있다.The composition for enhancing immunity of the present invention contains deer antler, cornflower oil and angelicae, which are known as major components of Gongjinjin, a representative oriental medicine prescription drug, and other medicinal substances, goji berries, turmeric, ginseng, ginseng, baechohyang, cheonma, cinnamon, omija, red ginseng, By including maekmundong and citrus powder in an appropriate ratio, it exhibits an immune-enhancing action, so it can be used for manufacturing Gamigongdiagnosis excluding musk. Accordingly, it is preferred that the composition of the present invention be processed in particular in the form of pills. In the form of pills, after extracting and concentrating the herbal medicine, each medicinal material is finely milled using a grinder, the extract and powder are mixed, and the powder mixed with the medicinal solution is put into a grinder again to be finely milled and filtered through a sieve of 300 to 500 mesh to fine particles. It can be made with honey and made into Hwan(丸), Dan(丹), Won(元), etc. At this time, for the convenience of taking, it is manufactured in units of 3.75 ~ 6g, and one to two tablets can be consumed per day. In addition, medicines made from pills, sweets, and circles can be packaged again using edible gold leaf (or silver foil). Gold or silver has been used to make pills since ancient times, and has been used as an auxiliary material in prescriptions such as Gongjinjin or Woohwangcheongsimwon because of its effect of stabilizing the mind and preventing insects. In addition, in another form, the process of making the pill is the same, and it can be used by extracting a drug that has been used as a dye from the past and has an insect repellent and antiseptic effect and coating it on the surface. A natural coating may be applied. Pills prepared with the composition for enhancing immunity of the present invention have a sweet and sour taste and thus increase edibility, so they can be used as preparations for children and adolescents as well as adults.
본 발명의 상기 조성물은 면역증강을 위한 약학적 제제 또는 건강기능식품으로 이용될 수 있다.The composition of the present invention may be used as a pharmaceutical preparation or health functional food for enhancing immunity.
따라서, 또 다른 양태로서, 본 발명은 상기 면역증강용 조성물과 약제학적으로 허용가능한 담체를 포함하는 면역질환 예방 또는 치료용 약학적 제제에 관한 것이다.Accordingly, in another aspect, the present invention relates to a pharmaceutical preparation for preventing or treating immune diseases, comprising the composition for enhancing immunity and a pharmaceutically acceptable carrier.
본 발명에서 "면역질환"은 생체의 면역체계 이상으로 유발되는 다양한 염증성 질환, 알러지성 질환 및 암 등을 포함하며, 예를 들면, 감기, 천식, 폐렴, 알러지성 비염, 알러지성 결막염, 아토피성 피부염, 알러지, 류마티스 관절염, 알츠하이머병, 자가면역성 갑상선 질환, 염증성 장질환, 재생불량성 빈혈, 홍반성 루푸스 및 건선 등을 포함할 수 있으나, 이에 제한되는 것은 아니다.In the present invention, "immune disease" includes various inflammatory diseases, allergic diseases and cancer caused by abnormalities in the immune system of a living body, for example, cold, asthma, pneumonia, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, allergy, rheumatoid arthritis, Alzheimer's disease, autoimmune thyroid disease, inflammatory bowel disease, aplastic anemia, lupus erythematosus and psoriasis, etc., but are not limited thereto.
본 발명의 상기 조성물은 면역질환 예방 또는 치료를 위한 약학적 조성물로 제공될 수 있으며, 담체와 함께 제제화될 수 있다. 상기 본 발명의 약학적 조성물은 각각 통상의 방법에 따라 산제, 과립제, 정제, 캡슐제, 현탁액, 에멀젼, 시럽, 에어로졸 등의 경구형 제형, 외용제, 좌제 및 멸균 주사용액의 형태로 제형화하여 사용될 수 있으며, 추출물을 포함하는 조성물에 포함될 수 있는 담체, 부형제 및 희석제로는 락토즈, 덱스트로즈, 수크로스, 솔비톨, 만니톨, 자일리톨, 에리스리톨, 말티톨, 전분, 아카시아 고무, 알지네이트, 젤라틴, 칼슘 포스페이트, 칼슘 실리케이트, 셀룰로즈, 메틸 셀룰로즈, 미정질 셀룰로스, 폴리비닐 피롤리돈, 물, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 탈크, 마그네슘 스테아레이트 및 광물유를 들 수 있다. 제제화할 경우에는 보통 사용하는 충진제, 증량제, 결합제, 습윤제, 붕해제, 계면활성제 등의 희석제 또는 부형제를 사용하여 조제된다. 경구투여를 위한 고형제제에는 정제, 환제, 산제, 과립제, 캡슐제 등이 포함되며, 이러한 고형제제는 상기 추출물에 적어도 하나 이상의 부형제 예를 들면, 전분, 칼슘카보네이트, 수크로스, 락토오스, 젤라틴 등을 섞어 조제된다. 또한, 단순한 부형제 이외에 마그네슘 스티레이트 탈크 같은 윤활제들도 사용된다. 경구를 위한 액상 제제로는 현탁제, 내용액제, 유제, 시럽제 등이 해당되는데 흔히 사용되는 단순희석제인 물, 리퀴드 파라핀 이외에 여러 가지 부형제, 예를 들면 습윤제, 감미제, 방향제, 보존제 등이 포함될 수 있다. 비경구투여를 위한 제제에는 멸균된 수용액, 비수성용제, 현탁제, 유제, 동결건조제제, 좌제가 포함된다. 비수성용제, 현탁제로는 프로필렌글리콜, 폴리에틸렌 글리콜, 올리브 오일과 같은 식물성 기름, 에틸올레이트와 같은 주사 가능한 에스테르 등이 사용될 수 있다. 좌제의 기제로는 위텝솔, 마크로골, 카카오지, 라우린지, 글리세로제라틴 등이 사용될 수 있다.The composition of the present invention may be provided as a pharmaceutical composition for the prevention or treatment of immune diseases, and may be formulated together with a carrier. The pharmaceutical composition of the present invention may be formulated in the form of powders, granules, tablets, capsules, suspensions, emulsions, syrups, aerosols, etc., external preparations, suppositories, and sterile injection solutions according to conventional methods, respectively. In addition, carriers, excipients and diluents that may be included in the composition comprising the extract include lactose, dextrose, sucrose, sorbitol, mannitol, xylitol, erythritol, maltitol, starch, acacia gum, alginate, gelatin, calcium phosphate , calcium silicate, cellulose, methyl cellulose, microcrystalline cellulose, polyvinyl pyrrolidone, water, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and mineral oil. In the case of formulation, it is prepared using commonly used diluents or excipients such as fillers, extenders, binders, wetting agents, disintegrants, and surfactants. Solid preparations for oral administration include tablets, pills, powders, granules, capsules, etc., and these solid preparations contain at least one excipient, for example, starch, calcium carbonate, sucrose, lactose, gelatin, etc. in the extract. prepared by mixing In addition to simple excipients, lubricants such as magnesium stearate talc are also used. Liquid formulations for oral use include suspensions, solutions, emulsions, syrups, etc. In addition to water and liquid paraffin, which are commonly used simple diluents, various excipients, for example, wetting agents, sweeteners, fragrances, preservatives, etc. may be included. . Formulations for parenteral administration include sterile aqueous solutions, non-aqueous solutions, suspensions, emulsions, freeze-dried preparations, and suppositories. Non-aqueous solvents and suspending agents include propylene glycol, polyethylene glycol, vegetable oils such as olive oil, and injectable esters such as ethyl oleate. As the base of the suppository, Witepsol, macrogol, cacao butter, laurin, glycerogelatin, and the like can be used.
본 발명의 조성물이 약학적 조성물로 이용될 때, 추출물은 전체 조성물 총 중량에 대하여 건조 중량 기준으로 0.0001 ~ 50중량%, 바람직하게는 0.1 ~ 20중량%의 함량으로 포함되어 제제화될 수 있다.When the composition of the present invention is used as a pharmaceutical composition, the extract may be formulated to be included in an amount of 0.0001 to 50% by weight, preferably 0.1 to 20% by weight, based on dry weight, based on the total weight of the total composition.
본 발명의 조성물의 바람직한 투여량은 환자의 건강 상태 및 체중, 질병의 정도, 약물형태, 투여경로 및 기간에 따라 다르지만, 당업자에 의해 적절하게 선택될 수 있다. 그러나, 바람직한 효과를 위해서, 본 발명의 조성물은 총 추출물의 건조 중량 기준으로 0.0001 내지 1000mg/kg, 바람직하게는 0.1 내지 100mg/kg의 양을 1일 1회 내지 수회로 나누어 투여할 수 있다.The preferred dosage of the composition of the present invention varies depending on the patient's health status and weight, the degree of disease, drug form, administration route and period, but may be appropriately selected by those skilled in the art. However, for a desirable effect, the composition of the present invention may be administered in an amount of 0.0001 to 1000 mg/kg, preferably 0.1 to 100 mg/kg, based on the dry weight of the total extract, once a day or divided into several times a day.
본 발명의 조성물의 투여 경로는 목적 조직에 도달할 수 있는 한 경구 또는 비경구의 다양한 경로를 통하여 투여될 수 있으며, 구체적으로, 구강, 직장, 국소, 정맥내, 복강내, 근육내, 동맥내, 경피, 비측내, 흡입, 안구내 또는 피내경로를 통해 통상적인 방식으로 투여될 수 있다. 바람직하게는 경구 투여한다.The route of administration of the composition of the present invention may be administered through various routes, either oral or parenteral, as long as it can reach the target tissue, and specifically, oral, rectal, topical, intravenous, intraperitoneal, intramuscular, intraarterial, It may be administered in a conventional manner via transdermal, intranasal, inhalation, intraocular or intradermal routes. Preferably, it is administered orally.
본 발명의 조성물은 임의의 동물에 적용가능하며, 동물은 인간 및 영장류뿐만 아니라, 소, 돼지, 양, 말, 개 및 고양이 등의 가축을 포함한다.The composition of the present invention is applicable to any animal, and the animal includes not only humans and primates, but also domestic animals such as cattle, pigs, sheep, horses, dogs and cats.
또한, 본 발명의 조성물은 염증 질환 및 알러지성 질환 등의 면역질환 예방 및 치료를 위하여 단독으로 사용하거나, 수술, 호르몬 치료, 약물 치료 및 생물학적 반응 조절제를 사용하는 방법들과 병용하여 사용할 수 있다.In addition, the composition of the present invention can be used alone for prevention and treatment of immune diseases such as inflammatory diseases and allergic diseases, or in combination with methods using surgery, hormone therapy, drug therapy, and biological response modifiers.
또 다른 양태로서, 본 발명은 상기 면역증강용 조성물을 포함하는 면역질환 개선 및 피로회복 증진용 건강기능식품에 관한 것이다.In another aspect, the present invention relates to a health functional food for improving immune disease and improving fatigue recovery comprising the composition for enhancing immunity.
본 발명의 상기 조성물은 염증 질환 및 알러지성 질환 등의 면역질환 예방 또는 개선이나 피로회복 증진을 위한 목적으로 건강기능식품에 첨가될 수 있다. 이때, 조성물에 포함되는 각 재료들은 추출물 형태 외에도 재료 자체를 분말화하여 추가로 첨가하는 방식으로도 이용될 수 있다.The composition of the present invention may be added to a health functional food for the purpose of preventing or improving immune diseases, such as inflammatory diseases and allergic diseases, or promoting recovery from fatigue. At this time, each material included in the composition may be used in a manner in which the material itself is powdered and additionally added in addition to the extract form.
상기 건강기능식품은 최종 제품의 상품성과 소비자 기호도에 따라 다른 식품소재를 첨가하여 제조될 수 있다.The health functional food may be manufactured by adding other food materials according to the marketability and consumer preference of the final product.
상기 조성물의 유효한 첨가량은 사용 목적(예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있으며, 바람직하게는 총 원료에 대하여 생약 건조 중량을 기준으로 0.01 내지 90중량%, 더욱 바람직하게는 5 내지 30중량%로 첨가될 수 있다.The effective addition amount of the composition may be appropriately determined depending on the purpose of use (prophylaxis, health or therapeutic treatment), preferably 0.01 to 90% by weight, more preferably 5 to 90% by weight based on the total raw material dry weight of the crude drug 30% by weight may be added.
본 발명의 면역증강용 조성물은 식품학적으로 허용가능한 식품첨가제를 추가로 포함하여 제제화함으로써 제제형태의 건강기능식품으로 제조할 수 있으며, 제제의 형태로는 정제, 캡슐제, 환제, 액제 등이 가능하다.The composition for enhancing immunity of the present invention can be prepared as a health functional food in the form of a formulation by further including a food additive, which is pharmaceutically acceptable, and can be a tablet, capsule, pill, liquid, etc. do.
또한, 상기 조성물을 첨가할 수 있는 식품의 종류에는 특별한 제한은 없다. 예를 들면, 음료수, 차, 빵, 쵸코렛, 캔디류, 스넥류 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 기능성 식품을 모두 포함한다.In addition, there is no particular limitation on the type of food to which the composition can be added. For example, there are beverages, tea, bread, chocolate, candies, snacks, and vitamin complexes, and includes all functional foods in a conventional sense.
또한, 본 발명의 건강기능식품은 다양한 향미제, 천연 탄수화물, 감미제, 비타민, 전해질, 착색제, 펙트산, 알긴산, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산화제 등을 추가로 함유할 수 있다. 특히, 상기 천연 탄수화물로는 포도당, 과당과 같은 모노사카라이드, 말토스, 수크로오스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜을 사용할 수 있으며, 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 이러한 첨가제의 비율은 크게 중요하진 않지만 본 발명의 조성물 100 ㎖ 당 0.01~10 g 정도의 범위에서 선택될 수 있다.In addition, the health functional food of the present invention includes various flavoring agents, natural carbohydrates, sweeteners, vitamins, electrolytes, colorants, pectic acid, alginic acid, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, carbonation agents and the like may be further contained. In particular, as the natural carbohydrate, monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol, and erythritol can be used. , As the sweetener, natural sweeteners such as taumatine and stevia extract, or synthetic sweeteners such as saccharin and aspartame can be used. The proportion of these additives is not very important, but may be selected in the range of about 0.01 to 10 g per 100 ml of the composition of the present invention.
본 발명에 따른 녹용, 당귀, 산수유, 구기자, 울금, 산약, 진피, 배초향, 천마, 계피, 오미자, 홍삼, 맥문동 및 감귤분말의 추출물을 유효성분으로 포함하는 면역증강용 조성물은 면역증강 활성을 나타내면서도 인체 안정성이 뛰어나, 면역질환 예방 또는 치료를 위한 약학적 제제 또는 건강기능식품 제조에 유용하게 이용될 수 있다.According to the present invention, the composition for enhancing immunity comprising extracts of antler, angelica, cornflower oil, goji berry, turmeric, ginseng, ginseng, baechohyang, cheonma, cinnamon, omija, red ginseng, maekmundong and citrus powder as active ingredients while exhibiting immune enhancing activity It also has excellent human stability, so it can be usefully used in the manufacture of pharmaceutical preparations or health functional foods for the prevention or treatment of immune diseases.
또한, 본 발명의 면역증강용 조성물은 면역력 증진, 자양강장, 수험생 체력증진 및 피로회복증진 등의 효과를 나타낼 뿐만 아니라, 환제 형태로 가공시 식감이 우수하여 사향이 제외된 가미공진단 제조에 이용될 수 있다.In addition, the composition for strengthening immunity of the present invention not only exhibits effects such as immunity enhancement, nourishment tonic, physical strength improvement and fatigue recovery improvement for test takers, but also has excellent texture when processed in the form of pills. can
또한, 본 발명의 조성물로 제조된 환제는 그 맛이 새콤달콤하여 취식성이 증대되므로, 성인뿐만 아니라, 특히, 어린이 및 청소년을 위한 제제로 이용될 수 있다.In addition, the pill prepared from the composition of the present invention has a sweet and sour taste, so the edibility is increased, so it can be used as a preparation for not only adults, but especially children and adolescents.
<실시예 1 내지 16><Examples 1 to 16>
녹용, 당귀, 산수유, 구기자, 울금, 산약, 진피, 배초향, 천마, 계피, 오미자, 홍삼, 맥문동, 정향, 작약, 숙지황, 복령, 건강, 우슬, 대추 및 애엽을 음건하고 세절하였다. 감귤은 분말을 사용하였다. 이들을, 각각 동일한 질량비로 하기 표 1에 따라 혼합하였다. 상기 혼합물에 각각의 혼합물 총 무게의 10배의 증류수를 가하고 10 시간 동안 끓여 열수 추출하였다. 상기 열수 추출물을 여과 후 감압 농축기를 이용하여 농축하였다.Deer antler, angelica, sansuyu, goji berry, turmeric, sanyak, ginseng, baechohyang, cheonma, cinnamon, omija, red ginseng, maekmundong, clove, peony, sukhukhwang, bokryeong, health, woosul, jujube and aeyeop were dried in the shade and chopped. Citrus powder was used. These were mixed according to Table 1 below in the same mass ratio, respectively. Distilled water 10 times the total weight of each mixture was added to the mixture, boiled for 10 hours, and hot water extraction was performed. The hot water extract was filtered and then concentrated using a vacuum concentrator.
<실험예 1><Experimental Example 1>
건강한 성인의 혈액을 채취하여 실온에서 약 15분간 방치하여 응고시킨 후, 응고된 혈액을 절단하고 약 5분간 상온에서 방치시킨다. 이 혈액을 다시 4℃에서 약 20분간 방치한 다음 원심분리(3,000 rpm, 20분, 4℃)하여 혈청을 분리한 뒤 미량 원심분리용 튜브에 1 mL씩 분주하여 -70℃에서 냉동 보관하여, 시험에 사용하였다.Blood from healthy adults is collected and allowed to clot at room temperature for about 15 minutes, then the clotted blood is cut and left at room temperature for about 5 minutes. This blood was left at 4°C for about 20 minutes and then centrifuged (3,000 rpm, 20 minutes, 4°C) to separate the serum, then dispensed 1 mL each into microcentrifuge tubes and stored frozen at -70°C, used in the test.
상기 혈청에 GVB++(gelatin veronal buffer, pH 7.4, 0.1% gelatin, 0.15 mM Ca++, 0.5 mM Mg++ 함유) 및 실시예 1 내지 16의 추출물을 각각 50 μL씩 혼합하여 37℃에서 30분간 1차 반응 시켰다. 그 후, GVB++ 350 μL를 가하고, 이를 10~160배 까지 연속 희석시켜, 750 μL의 GVB++와 양의 감작적혈구 (Ig M-sensitizated sheeperythrocyte, EA cell, 1× 108cells/mL) 250 μL를 가하여 37℃에서 50분간 2차 반응시켰다. 그 후 PBS(phosphate buffered saline, pH 7.4) 2.5 mL를 가하여 반응을 정지시켰다. 상기 반응액은 2,000 rpm에서 10분간 원심분리하였으며, 얻어진 상등액을 412 nm에서 흡광도를 측정하여 잔존 용혈활성을 측정하였다.GVB++ (gelatin veronal buffer, pH 7.4, 0.1% gelatin, 0.15 mM Ca++, 0.5 mM Mg++ containing) and 50 μL of each of the extracts of Examples 1 to 16 were mixed in the serum, followed by a primary reaction at 37° C. for 30 minutes. Then, add 350 μL of GVB++, serially dilute it 10 to 160 times, add 750 μL of GVB++ and 250 μL of sheep sensitized red blood cells (Ig M-sensitized sheeperythrocyte, EA cell, 1×10 8 cells/mL). Secondary reaction was carried out at 37°C for 50 minutes. Then, 2.5 mL of PBS (phosphate buffered saline, pH 7.4) was added to stop the reaction. The reaction solution was centrifuged at 2,000 rpm for 10 minutes, and the residual hemolytic activity was measured by measuring the absorbance of the obtained supernatant at 412 nm.
항보체 활성은 정상인의 혈청과 GVB++, 증류수만을 반응시킨 음성대조군의 총보체용혈(50% total complementhemolysis, TCH50, %)에 대한 저지율(inhibition of 50% total complement hemolysis, ITCH50, %)로써 나타내었다. 양성대조군으로는 polysaccharide K(PSK)를 사용하였다.Anti-complement activity was expressed as inhibition of 50% total complement hemolysis (ITCH 50 , %) against total complement hemolysis (50% total complement hemolysis, TCH 50 , %) of a negative control group in which only normal human serum, GVB++, and distilled water were reacted. it was Polysaccharide K (PSK) was used as a positive control.
<식 1><Equation 1>
ITCH50 (%)=(대조군의TCH50-실시예의 TCH50 / 실시예의TCH50) X 100ITCH 50 (%)=(TCH 50 of control - TCH 50 of Example / TCH 50 of Example) X 100
그 결과, 실시예 2, 3, 8, 12, 13 및 16의 ITCH50이 높은 것으로 확인되었다(표 2). 그러므로 항보체 활성이 높은 녹용, 당귀, 산수유, 구기자, 울금, 산약, 진피, 배초향, 천마, 계피, 오미자, 홍삼, 맥문동 및 감귤을 이용하여 이후의 실험을 진행하였다.As a result, it was confirmed that the ITCH 50 of Examples 2, 3, 8, 12, 13 and 16 was high (Table 2). Therefore, subsequent experiments were carried out using antler, angelica, cornflower, goji berry, turmeric, sanyak, ginpi, baechohyang, cheonma, cinnamon, omija, red ginseng, maekmundong, and tangerine with high anticomplement activity.
<실시예 17~32><Examples 17-32>
녹용, 당귀, 산수유, 구기자, 울금, 산약, 진피, 배초향, 천마, 계피, 오미자, 홍삼, 맥문동 및 감귤을 하기 표3의 질량비로 혼합하였다. 상기 혼합물에 각각의 혼합물 총 무게의 10배의 증류수를 가하고 10 시간 동안 끓여 열수 추출하였다. 상기 열수 추출물을 여과 후 감압 농축기를 이용하여 농축하였다.Deer antler, angelica, sansuyu, goji berry, turmeric, sanyak, ginseng, baechohyang, cheonma, cinnamon, omija, red ginseng, maekmundong and tangerine were mixed in the mass ratio shown in Table 3 below. Distilled water 10 times the total weight of each mixture was added to the mixture, boiled for 10 hours, and hot water extraction was performed. The hot water extract was filtered and then concentrated using a vacuum concentrator.
<실험예 2><Experimental Example 2>
비장(spleen)은 혈액으로부터 항원을 수집하여, B 및 T 림프구의 성숙과 항원에 의해 자극받은 후 림프구의 분화가 이루어지는 주요 림프기관으로 비장 내 림프구의 증식은 면역시스템에 있어 매우 중요한 의미를 갖는다.The spleen is a major lymphoid organ that collects antigens from blood, matures B and T lymphocytes, and differentiates lymphocytes after being stimulated by antigens. The proliferation of lymphocytes in the spleen has a very important meaning for the immune system.
6~8주령 암컷 Balb/c 마우스를 1 주일 동안 23 ℃, 40-60 % 습도, 12시간 명암주기 조건환경에서 적응시켰다. 그 후, 실시예 17~32의 추출물을 70 ml/kg 의 용량으로 첨가하여 일반 사료(퓨리나)와 함께 1달 간 투여하고, 혈액을 채취하였다. 형광색소(FITC, PE)를 이용하여 염색 후 유세포분석기(flow cytometry)를 이용하여 상기 혈액 내 총 T 림프구 및 총 B 림프구의 수를 측정하였다(표 4).6-8 week old female Balb/c mice were acclimatized to 23 °C, 40-60% humidity, and light-dark cycle conditions for 1 week. Then, the extracts of Examples 17-32 were added at a dose of 70 ml/kg, administered together with a general feed (purina) for 1 month, and blood was collected. After staining with fluorescent dyes (FITC, PE), the number of total T lymphocytes and total B lymphocytes in the blood was measured using flow cytometry (Table 4).
*B 림프구 및 T 림프구는 세포수 X 105으로 나타냄.*B lymphocytes and T lymphocytes are expressed as the number of cells X 10 5 .
그 결과, 실시예 17, 21, 22, 25, 26, 30, 31 및 32의 추출물을 투약 시 면역 증강 효능이 높아지는 것을 확인하였다. 이를 종합하여 보면, 녹용, 당귀, 산수유, 구기자, 울금, 산약, 진피, 배초향, 천마, 계피, 오미자, 홍삼, 맥문동 및 감귤 분말을 각각 5~25: 5~25: 5~25: 5~25: 10~15: 10~15: 10~15: 10~15: 1~5: 1~5: 1~5: 1~5: 1~5: 1~5 의 질량비로 혼합하여 열수추출하는 것이 효과가 좋았다.As a result, it was confirmed that the immune enhancing effect was increased when the extracts of Examples 17, 21, 22, 25, 26, 30, 31 and 32 were administered. In summary, antler, angelica, cornflower oil, goji berry, turmeric, sanyak, ginseng, baechohyang, cheonma, cinnamon, omija, red ginseng, maekmundong and citrus powder 5-25: 5-25: 5-25: 5-25 : 10~15: 10~15: 10~15: 10~15: 1~5: 1~5: 1~5: 1~5: 1~5: It is effective to extract hot water by mixing in a mass ratio of 1~5 was good
Claims (6)
각 구성성분의 함량은 녹용 10~15질량비, 당귀 10~15질량비, 산수유 10~15질량비, 구기자 10~15질량비, 울금 8~12질량비, 산약 8~12질량비, 진피 8~12질량비, 배초향 8~12질량비, 천마 1~4질량비, 계피 1~4질량비, 오미자 1~4질량비, 홍삼 1~4질량비, 맥문동 1~4질량비 및 감귤분말 1~4질량비로 포함되는 것을 특징으로 하는, 면역증강용 조성물.Contains extracts of deer antler, angelica, sansuyu, goji berry, turmeric, sanyak, ginseng, baechohyang, cheonma, cinnamon, omija, red ginseng, maekmundong and citrus powder as active ingredients,
The content of each component is: antler 10-15 mass ratio, angelica 10-15 mass ratio, cornflower oil 10-15 mass ratio, goji berry 10-15 mass ratio, turmeric 8-12 mass ratio, sanyak 8-12 mass ratio, dermis 8-12 mass ratio, baechohyang 8 ~12 mass ratio, cheonma 1-4 mass ratio, cinnamon 1-4 mass ratio, omija 1-4 mass ratio, red ginseng 1-4 mass ratio, maekmundong 1-4 mass ratio, and citrus powder 1-4 mass ratio, characterized in that it is included, immunity enhancement for composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200174448A KR20220085088A (en) | 2020-12-14 | 2020-12-14 | Food additives to improve immune diseases using herbal medicines from Kamigongjindan |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200174448A KR20220085088A (en) | 2020-12-14 | 2020-12-14 | Food additives to improve immune diseases using herbal medicines from Kamigongjindan |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220085088A true KR20220085088A (en) | 2022-06-22 |
Family
ID=82217000
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200174448A KR20220085088A (en) | 2020-12-14 | 2020-12-14 | Food additives to improve immune diseases using herbal medicines from Kamigongjindan |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20220085088A (en) |
-
2020
- 2020-12-14 KR KR1020200174448A patent/KR20220085088A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101279598B1 (en) | Composition for immune enhancement comprising the extract of Young antler, Cornus officinalis, Ligusticum acutilobum, Aurantii nobilis pericarpium, Chinese matrimony vine, lotus root, Yam, Curcuma aromatica Salisb, Gastrodia elata blume, Agastache rugosa, Cinnamomum loureirii, Ginseng steamed red and Schizandra chinensis, as active ingredient | |
KR101229254B1 (en) | Composition for immune enhancement comprising the extract of Young antler, Ligusticum acutilobum, Cornus officinalis, Chinese matrimony vine, Curcuma aromatica Salisb, Yam, Aurantii nobilis pericarpium, Agastache rugosa, Gastrodia elata blume, Cinnamomum loureirii, Schizandra chinensis, Ginseng steamed red, snake's beard and citrus powder, as active ingredient | |
KR100998225B1 (en) | Immuno-enhancing composition comprising extracts of Deer Antler, Cornus, Angelica, Gugija, Chinese medicine, Dermis, Cheonma, Pearweed, Cinnamon, Red ginseng, and Schisandra chinensis as active ingredients | |
KR20120007275A (en) | Immune Enhancing Composition Containing Plant Mixture Extract | |
KR20230057438A (en) | Compositions of ginsenosides Rg3 and ginsenosides Rg5 and pharmaceutical uses thereof, including antitumor effects | |
Nirmala et al. | Promising underutilized wild plants of cold desert Ladakh, India for nutritional security and health benefits | |
KR20150037109A (en) | Manufacturing method of composition of health food containing wild ginseng and herb extracts and composition of health food containing wild ginseng and herb extracts manufactured by the same | |
WO2016117705A1 (en) | Agent for inducing production of hepatocyte growth factor | |
US20180214504A1 (en) | Health supplement food for promotion of hair growth, mitigation and alleviation of hair loss, regulation of blood glucose, and alleviation and relief of gastric disorder symptoms | |
CN108813501B (en) | Health-preserving honey paste with functions of clearing heat, moistening lung, relieving cough, reducing phlegm, relieving asthma and regulating human body functions | |
KR20160119999A (en) | Gongjindan based on dongibogam and method of manufacturing the same | |
KR101336094B1 (en) | Functional food composition for improving skin condition and preparation method thereof | |
KR20160000695A (en) | Herbal-medicine containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
KR101525877B1 (en) | A composition for preventing wrinkle of skin and anti aging of skin | |
KR102217732B1 (en) | Composition for preventing and improving the development of premature pseudo-breast | |
KR20220085088A (en) | Food additives to improve immune diseases using herbal medicines from Kamigongjindan | |
WO2023100764A1 (en) | Composition for preventing, improving or alleviating symptoms relating to qi deficiency and/or blood deficiency | |
Sharma et al. | Adaptogens: new age healing gems for physical wellbeing | |
KR101479096B1 (en) | Health functional food comprising extracts of herbal mixture for preventing or improving edema of delivered or pregnant woman | |
CN108567854A (en) | Join Ling oral liquid and preparation method thereof | |
WO2022091901A1 (en) | Composition for preventing, improving, or alleviating menstrual symptoms | |
Algethami et al. | Bee pollen: Clinical trials and patent applications. Nutrients. 2022, 14, 2858 | |
CN105638961A (en) | Dark green tea composition with ramie leaves and preparation method thereof | |
KR101717755B1 (en) | The method for manufacturing red ginseng functional beverage and the functional beverage made by the method | |
KR102675725B1 (en) | Herbal pill composition for anti-inflammatory and immune enhancement containing Paeonia lactiflora and Cinnamomum cassia Blume and its preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20201214 |
|
PG1501 | Laying open of application |